- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Acute Myeloid Leukemia in United States
Total 3569 results
-
University of ChicagoNational Cancer Institute (NCI)CompletedAcute Myeloid LeukemiaUnited States
-
University of Colorado, DenverCelgeneCompletedAcute Myeloid LeukemiaUnited States
-
University of FloridaNovartis PharmaceuticalsWithdrawnAcute Myeloid LeukemiaUnited States
-
Bruno C. MedeirosSchering-PloughCompletedLeukemia, MyeloidUnited States
-
Novartis PharmaceuticalsTerminatedAcute Myeloid LeukemiaUnited States
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingAcute Myeloid Leukemia | Myeloid Leukemia | Monocytic LeukemiaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Yale UniversityBristol-Myers Squibb; National Cancer Institute (NCI)WithdrawnAcute Myeloid LeukemiaUnited States
-
University of IowaTerminatedAcute Myeloid LeukemiaUnited States
-
Washington University School of MedicineCelgene CorporationCompleted
-
Washington University School of MedicineCompleted
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia With Minimal Differentiation | Adult Acute... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAdult Acute Promyelocytic Leukemia (M3) | Childhood Acute Promyelocytic Leukemia (M3) | Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) | Adult Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedAcute Myeloid Leukemia | Leukemia | AMLUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Spectrum Pharmaceuticals, IncTerminatedVincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaRecurrent Adult Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of HealthRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
Brian JonasNational Cancer Institute (NCI); GlycoMimetics IncorporatedRecruitingUproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid LeukemiaAcute Myeloid LeukemiaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingAcute Myeloid LeukemiaUnited States
-
University of ChicagoAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid LeukemiaUnited States
-
University of WashingtonTerminatedAcute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalTakedaCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterEli Lilly and Company; High Impact Clinical Research Support ProgramCompleted
-
Ashkan EmadiCompletedAcute Myeloid LeukemiaUnited States
-
Altor BioScienceM.D. Anderson Cancer CenterWithdrawnAcute Myeloid LeukemiaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Alison WalkerNovartis; Millennium Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid... and other conditionsUnited States
-
Carevive Systems, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Oscotec Inc.PPDCompletedAcute Myeloid LeukemiaUnited States
-
Columbia UniversityThe Leukemia and Lymphoma SocietyCompletedAcute Myeloid LeukemiaUnited States
-
UNC Lineberger Comprehensive Cancer CenterCelgeneCompletedAcute Myeloid LeukemiaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Myeloid LeukemiaUnited States
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer CenterTerminatedAcute Myeloid Leukemia | Acute Leukemia of Ambiguous LineageUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteESP PharmaTerminatedAcute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Promyelocytic Leukemia With PML-RARAUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Adult Acute Myeloid Leukemia...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Thomas A. Lane, MDTerminated
-
Masonic Cancer Center, University of MinnesotaCompletedLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Myelofibrosis | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | MDS | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Refractory AnemiaUnited States
-
NewLink Genetics CorporationCompletedAcute Myeloid LeukemiaUnited States
-
AbbVieSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia (AML)United States, Germany, United Kingdom
-
Masonic Cancer Center, University of MinnesotaUniversity of MinnesotaWithdrawnSecondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Treatment-Related Acute Myeloid Leukemia | High-Risk Acute Myeloid LeukemiaUnited States
-
Stanford UniversityVarian Medical Systems, Inc.RecruitingAcute Myeloid LeukemiaUnited States